You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 38 No. 10, October 1981 TABLE OF CONTENTS
  Archives
  •  Online Features
  SPECIAL ARTICLE
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Heredopathia Atactica Polyneuritiformis

Phytanic-Acid Storage Disease, Refsum's Disease: A Biochemically Well-defined Disease With a Specific Dietary Treatment

Sigvald Refsum, MD

Arch Neurol. 1981;38(10):605-606.


Abstract

• Heredopathia atactica polyneuritiformis (phytanic-acid storage disease, Refsum's disease) is an inborn error of metabolism, in which the body accumulates exogenous phytanic acid. The severe manifestations of this disease, which include pigmentary retinal degeneration, chronic polyneuropathy, ataxia, impaired hearing, and cardiopathy, can be either kept from worsening or reversed by elimination of foods rich in phytanic acid from patients' diets. This is borne out by a 20-year experience with two patients, whose conditions improved markedly once they stopped eating butter, animal fat, and other foods rich in phytanic acid.



Author Affiliations

From the Department of Neurology, Rikshospitalet, Oslo.


Footnotes

Accepted for publication Jan 26, 1981.

Reprint requests to World Federation of Neurology, Department of Neurology, Rikshospitalet, Oslo 1, Norway (Dr Refsum).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

CYP4 Isoform Specificity in the {omega}-Hydroxylation of Phytanic Acid, a Potential Route to Elimination of the Causative Agent of Refsum's Disease
Xu et al.
J. Pharmacol. Exp. Ther. 2006;318:835-839.
ABSTRACT | FULL TEXT  

Advances in genetics: what are the benefits for patients?
Munnich
J. Med. Genet. 2006;43:555-556.
FULL TEXT  

Smell testing: an additional tool for identification of adult Refsum's disease
Gibberd et al.
J. Neurol. Neurosurg. Psychiatry 2004;75:1334-1336.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.